Fertilizer giant CF Industries picked up an upgrade on Monday. Analysts bumped the stock higher as the consensus target price rose to $125.47, up from $122.58. The stock carries a $19.2B market cap. Short interest sits at a modest 5.9% of free float, suggesting limited bearish conviction.
Regeneron Pharmaceuticals faced multiple analyst changes in the same session. The consensus target dropped to $839.81 from $867.88 — a $28 cut. Analysts moved from 21 sells to 20, but the average price target still moved lower. The pharma giant holds a $69.8B market cap.
Boston Scientific saw its target trimmed to $83.44 from $84.71. With 30 buy ratings and zero sells, the medtech remains a Wall Street favourite. Short interest is just 1.9% of free float.
Block had a busy day. Canaccord Genuity's Joseph Vafi raised his target to $85 from $80, maintaining a Buy. The broader consensus target edged up to $90.20.
Ross Stores also got a target boost from UBS. Jay Sole lifted his price to $227 from $208, keeping a Hold rating. UBS sees upside to the discount retailer despite macro uncertainty.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
